Biomarin Pharmaceutical Inc (BMRN)

Payables turnover

Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020
Cost of revenue US$ in thousands 580,235 532,062 483,669 470,515 524,272
Payables US$ in thousands — — — — —
Payables turnover — — — — —

December 31, 2024 calculation

Payables turnover = Cost of revenue ÷ Payables
= $580,235K ÷ $—K
= —

The payables turnover ratio for Biomarin Pharmaceutical Inc for the year ended December 31, 2020, and subsequent years through December 31, 2024, is not provided in the data. The payables turnover ratio indicates the efficiency with which a company manages its accounts payable by paying its suppliers. Without the specific values for each year, it is challenging to assess the company's ability to efficiently utilize its accounts payable balance. Further information or data is required to conduct a detailed analysis of Biomarin Pharmaceutical Inc's payables turnover.